ZNF329 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.45916612126484E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.20770000000547E-06 |
Normal-vs-Stage2 |
6.66090000045472E-07 |
Normal-vs-Stage3 |
1.02760022713255E-11 |
Normal-vs-Stage4 |
1.62592161956354E-12 |
Stage1-vs-Stage2 |
1.733690E-02 |
Stage1-vs-Stage3 |
9.66470000000053E-05 |
Stage1-vs-Stage4 |
3.35119999528288E-08 |
Stage2-vs-Stage3 |
3.748000E-01 |
Stage2-vs-Stage4 |
6.516300E-02 |
Stage3-vs-Stage4 |
3.672400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.98652205796179E-12 |
Normal-vs-AfricanAmerican |
5.568100E-04 |
Normal-vs-Asian |
7.838600E-01 |
Caucasian-vs-AfricanAmerican |
1.485170E-01 |
Caucasian-vs-Asian |
8.232000E-02 |
AfricanAmerican-vs-Asian |
2.886000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.63247193540883E-12 |
Normal-vs-Female |
2.06619999998381E-06 |
Male-vs-Female |
1.561530E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.01560000001599E-06 |
Normal-vs-Age(41-60Yrs) |
5.90140003531303E-09 |
Normal-vs-Age(61-80Yrs) |
9.11382080914791E-13 |
Normal-vs-Age(81-100Yrs) |
1.68079999995907E-06 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.491800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.618400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.165000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.670830E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.153600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.789800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
7.410400E-01 |
Normal-vs-Grade 2 |
2.62360000002904E-06 |
Normal-vs-Grade 3 |
2.02726724296554E-13 |
Normal-vs-Grade 4 |
1.62436730732907E-12 |
Grade 1-vs-Grade 2 |
2.605500E-02 |
Grade 1-vs-Grade 3 |
1.524470E-03 |
Grade 1-vs-Grade 4 |
1.60979999996869E-07 |
Grade 2-vs-Grade 3 |
5.77239999999257E-05 |
Grade 2-vs-Grade 4 |
7.42910177820022E-11 |
Grade 3-vs-Grade 4 |
1.739150E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
6.30120000000289E-05 |
Normal-vs-ccB subtype |
9.05941988094128E-14 |
ccA subtype-vs-ccB subtype |
8.40929999967877E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.51049958599481E-10 |
Normal-vs-N1 |
3.60399998733385E-09 |
N0-vs-N1 |
4.359500E-02 |
|
|